POLICY ON NEW DRUG APPLICATION: 1. The content of New Drug Application (NDA) should b ...

Permission to conduct clinical performance evaluation for new in vitro diagnostic me ...

19.0 Clinical Evidence: The device master file should contain the Clinical Evidence, ...

THE DEPARTMENT OF SCIENTIFIC AND INDUSTRIAL RESEARCH (DSIR) In India serves as a ke ...

The clients receive outstanding value from accredited Consultancy's high-quality, aff ...

Accredited Consultants The clients receive outstanding value from accredited Consulta ...

14.0 Definition of Assay Cut-off: This section should provide a summary of analytical ...

This amendment is an important milestone as until now, only colistin was prohibited i ...